Skip Navigation U.S. Department of Health and Human Services
Agency for Healthcare Research Quality
Archive print banner

Blood Pressure Monitoring

This information is for reference purposes only. It was current when produced and may now be outdated. Archive material is no longer maintained, and some links may not work. Persons with disabilities having difficulty accessing this information should contact us at: Let us know the nature of the problem, the Web address of what you want, and your contact information.

Please go to for current information.

Full Title: Utility of Blood Pressure Monitoring Outside of the Clinic Setting

November 2002

View or download Summary/Report

Structured Abstract

Objectives: Ambulatory BP (ABP) and self-measured BP (SMBP) monitoring are two techniques that record frequent BP outside of the clinic setting. The overall objective of this report was to summarize evidence on the clinical utility of ABP and SMBP monitoring.

Search Strategy: Electronic searches were completed of MEDLINE®, Cochrane Collaboration CENTRAL Register of Controlled Trials, and HealthSTAR. Hand searching was completed of key journals, conference proceedings and references lists. Electronic searching was completed to March 2001, and hand searching was completed to May 2001.

Selection Criteria: Articles were included in this evidence synthesis if they were English-language reports of original data that addressed one of the specific research questions in nonpregnant adults.

Main Results: Eighteen studies compared clinic BP, SMBP, and/or ABP. For both systolic and diastolic BP, clinic measurements exceeded SMBP and ABP. Few studies compared SMBP and ABP. Sixteen studies determined the prevalence of white coat hypertension (WCH).

Overall, WCH prevalence was approximately 20 percent among hypertensives but varied considerably by definition. Few studies assessed the reproducibility of WCH (two studies) or the reproducibility of differences between clinic BP and either ABP (one study). In cross-sectional studies of BP with left ventricular mass and/or albuminuria (25 studies), ABP levels were directly associated with both measurements; also, left ventricular mass was less in individuals with WCH than in those with sustained hypertension. Ten prospective studies assessed the relationship of ABP with subsequent clinical outcomes. In each study, at least one dimension of ABP predicted outcomes. WCH predicted a reduced risk of CVD events compared to sustained hypertension. However, data were inadequate to compare the risk associated with WCH to the risk associated with normotension. A nondipping or inverse dipping pattern predicted an increased risk of clinical outcomes. The literature was insufficient to determine whether absolute SMBP levels or WCH based on SMBP was associated with left ventricular mass or proteinuria (just one study) or whether SMBP measurements predicted subsequent CVD (just one study).

In both cross-sectional and prospective studies, the poor or uncertain quality of clinic measurements precluded a satisfactory comparison of SMBP and ABP with clinic BP. Twelve trials assessed whether use of SMBP had an impact on BP control. In half of these studies, including two trials that tested contemporary devices, use of SMBP was associated with reduced BP. The availability of just two ABP trials limited inferences about the utility of ABP to guide BP management.

In general, few studies reported enrollment of African-Americans. Studies infrequently reported results stratified by gender. The only notable subgroup finding was a higher prevalence of WCH in women than men.

Conclusions: In cross-sectional studies, ABP levels and ABP patterns were associated with BP-related target organ damage. Likewise, in prospective studies, higher ABP, sustained BP, and a nondipping ABP pattern were associated with an increased risk of subsequent CVD events. Few studies examined corresponding relationships for SMBP. An inadequate number of clinic BP measurements, as well as the poor or uncertain quality of these measurements, precluded satisfactory comparisons of risk prediction based on ABP or SMBP with risk prediction based on clinic BP.

In aggregate, these findings provide some evidence that ABP monitoring is useful in evaluating prognosis. However, evidence was insufficient to determine whether the risks associated with WCH are sufficiently low to consider withholding drug therapy in this large subgroup of hypertensive patients. For SMBP, available evidence suggested that use of SMBP can improve BP control; however, further trials that evaluate contemporary SMBP devices are needed.

Download Report

Utility of Blood Pressure Monitoring Outside of the Clinic Setting

Evidence-based Practice Center: Johns Hopkins University
Topic Nominator: National Heart, Lung, and Blood Institute's National High Blood Pressure Education Program

Current as of November 2002


The information on this page is archived and provided for reference purposes only.


AHRQ Advancing Excellence in Health Care